Hope for cancer patients as scientists report breakthrough in personalised cancer vaccines
Researchers in the United States have reported promising results from a personalised cancer vaccine designed to prevent melanoma from returning or spreading. The vaccine, known as intismeran autogene, is being developed by Moderna, a biotechnology company, in partnership with Merck, a biopharmaceuti...
Sentiment: Negative (
-0.77
)
Bias: Neutral
Fact-Checked Information
Source:
Google Fact Check Tools
Reliability:
Unknown
Notes:
No fact-checks found for this content
Verified on Aug 23, 2026